Deciphera Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:DCPH Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Feb 24	SellUS$35,405	Jama Pitman	Individual	2,267	US$15.62
16 Feb 24	SellUS$35,405	Daniel Martin	Individual	2,267	US$15.62
16 Feb 24	SellUS$47,009	Thomas Kelly	Individual	3,010	US$15.62
16 Feb 24	SellUS$40,840	Matthew Sherman	Individual	2,615	US$15.62
16 Jan 24	SellUS$23,499	Daniel Martin	Individual	1,624	US$14.47
16 Jan 24	SellUS$35,234	Thomas Kelly	Individual	2,435	US$14.47
16 Jan 24	SellUS$23,499	Jama Pitman	Individual	1,624	US$14.47
16 Jan 24	SellUS$35,234	Matthew Sherman	Individual	2,435	US$14.47
13 Dec 23	SellUS$42,905	Matthew Sherman	Individual	2,792	US$15.37
13 Dec 23	SellUS$26,539	Daniel Martin	Individual	1,727	US$15.37
13 Dec 23	SellUS$42,905	Thomas Kelly	Individual	2,792	US$15.37
13 Dec 23	SellUS$25,540	Jama Pitman	Individual	1,662	US$15.37
13 Dec 23	SellUS$471,217	Steven Hoerter	Individual	30,664	US$15.37
30 Nov 23	SellUS$223,755	Daniel Martin	Individual	17,801	US$12.57
30 Oct 23	SellUS$259,256	Steven Hoerter	Individual	21,573	US$12.02
30 Oct 23	SellUS$28,362	Matthew Sherman	Individual	2,360	US$12.02
30 Oct 23	SellUS$27,833	Thomas Kelly	Individual	2,316	US$12.02
30 Oct 23	SellUS$16,909	Daniel Martin	Individual	1,407	US$12.02
30 Oct 23	SellUS$16,909	Jama Pitman	Individual	1,407	US$12.02
02 Oct 23	SellUS$37,305	Matthew Sherman	Individual	2,942	US$12.68
16 Jun 23	SellUS$23,835	Daniel Flynn	Individual	1,655	US$14.40
16 Jun 23	SellUS$17,829	Daniel Martin	Individual	1,238	US$14.40
16 Jun 23	SellUS$23,835	Thomas Kelly	Individual	1,655	US$14.40
16 Jun 23	SellUS$23,835	Matthew Sherman	Individual	1,655	US$14.40
16 Jun 23	SellUS$17,829	Jama Pitman	Individual	1,238	US$14.40
08 Jun 23	BuyUS$138,828	Frank Friedman	Individual	10,000	US$13.88
10 May 23	BuyUS$152,416	Dennis Walsh	Individual	11,000	US$13.86

Insider Trading Volume

Insider Buying: DCPH insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of DCPH?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	8,476	0.0102%
Individual Insiders	615,193	0.744%
Hedge Funds	15,789,564	19.1%
VC/PE Firms	23,059,708	27.9%
Institutions	43,244,029	52.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.2%.

Top Shareholders

Top 25 shareholders own 85.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
28.1%	Brightstar Associates, LLC	23,059,708	US$338.3m	0%	no data
7.27%	BlackRock, Inc.	5,976,266	US$87.7m	9.68%	no data
7.04%	Deerfield Management Company, L.P. Series C	5,788,024	US$84.9m	-16.1%	1.82%
6.33%	Armistice Capital LLC	5,200,000	US$76.3m	12.8%	2.06%
5.84%	Redmile Group, LLC	4,801,540	US$70.4m	7.29%	2.97%
5.36%	The Vanguard Group, Inc.	4,401,636	US$64.6m	0.76%	no data
3.01%	State Street Global Advisors, Inc.	2,470,813	US$36.2m	6.91%	no data
2.55%	Morgan Stanley, Investment Banking and Brokerage Investments	2,097,025	US$30.8m	60.1%	no data
2.25%	Polar Capital Holdings Plc	1,850,000	US$27.1m	5.71%	0.12%
2.21%	Goldman Sachs Group, Investment Banking and Securities Investments	1,817,391	US$26.7m	27.3%	0.01%
1.9%	Dimensional Fund Advisors LP	1,561,654	US$22.9m	6.29%	no data
1.72%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,410,239	US$20.7m	7.39%	0.01%
1.49%	Geode Capital Management, LLC	1,221,308	US$17.9m	7.45%	no data
1.46%	Emerald Advisers, LLC	1,197,526	US$17.6m	0%	0.44%
1.42%	Braidwell LP	1,169,490	US$17.2m	-65%	1.33%
1.24%	Frazier Life Sciences Management, LP	1,021,800	US$15.0m	176%	0.72%
1.12%	Jefferies Financial Group Inc.,Asset Management Arm	917,515	US$13.5m	24.2%	0.26%
0.99%	Assenagon Asset Management S.A.	809,923	US$11.9m	0%	0.03%
0.79%	Millennium Management LLC	652,254	US$9.6m	84.2%	0.01%
0.7%	New Leaf Venture Partners, LLC	576,975	US$8.5m	-52.3%	8.59%
0.68%	Parkman Healthcare Partners LLC	561,025	US$8.2m	-6.09%	1.17%
0.64%	UBS Asset Management AG	526,367	US$7.7m	14.1%	no data
0.64%	Northern Trust Global Investments	525,503	US$7.7m	0.96%	no data
0.63%	Charles Schwab Investment Management, Inc.	515,301	US$7.6m	0%	no data
0.61%	Medical Strategy GmbH, Asset Management Arm	504,500	US$7.4m	0%	0.46%